Literature DB >> 22167015

Cytokine profiles in peripheral blood of children and adults with Crohn disease.

Seung Pak1, Nina Holland, Elizabeth A Garnett, Elizabeth Mileti, Uma Mahadevan, Rachel Beckert, Bittoo Kanwar, Melvin B Heyman.   

Abstract

BACKGROUND: Increasing evidence suggests that cytokine dysregulation in T-helper 1 and T-helper 2 (TH1/TH2) subsets contributes to the pathogenesis of Crohn disease (CD). The present pilot study examines the hypothesis that cytokine profiles differ between pediatric and adult patients with CD.
METHODS: Production of TH1 cytokines interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) and of TH2 cytokines interleukin-4 (IL-4) and IL-6 was analyzed in peripheral blood of patients with CD and healthy controls (n=20) using flow cytometry after in vitro stimulation.
RESULTS: In both pediatric and adult subjects, frequencies of TNFCD4+ T cells were higher in patients with CD than in controls (P=0.009 and P=0.047, respectively). Percentages of cells expressing IL-4 were slightly increased (P=0.036), whereas those for IFN-γ were decreased (P=0.009) in pediatric patients with CD compared with controls. As expected, the overall production of TH1 cytokines was higher in adults compared with pediatric subjects. When memory CD4+CD45RO+ T cells were considered, lower IFN-γ expression was observed in pediatric subjects with CD compared with controls (P=0.009), matching the trend seen in the general CD4+ T cell population. The percentage of CD4+CD45RO+ T cells was increased in adult patients with CD compared with pediatric patients with CD (P=0.016).
CONCLUSIONS: The present study describes a peripheral blood TH1/TH2 cytokine imbalance in CD and suggests different immunological mechanisms in children and adults for disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22167015      PMCID: PMC3339044          DOI: 10.1097/MPG.0b013e3182455bb3

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  37 in total

1.  Distinctive pattern of cytokine production and adhesion molecule expression in peripheral blood memory CD4+ T cells from patients with active Crohn's disease.

Authors:  Jaime García de Tena; Luis Manzano; Juan Carlos Leal; Esther San Antonio; Verónica Sualdea; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

2.  Cytokine responses correlate differentially with age in infancy and early childhood.

Authors:  C Härtel; N Adam; T Strunk; P Temming; M Müller-Steinhardt; C Schultz
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

Review 3.  T cells and cytokines in Crohn's disease.

Authors:  P Romagnani; F Annunziato; M C Baccari; P Parronchi
Journal:  Curr Opin Immunol       Date:  1997-12       Impact factor: 7.486

4.  Interleukin-4- and -13-induced hypercontractility of human intestinal muscle cells-implication for motility changes in Crohn's disease.

Authors:  Hirotada Akiho; Paola Lovato; Yikang Deng; Peter J M Ceponis; Patricia Blennerhassett; Stephen M Collins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-11-04       Impact factor: 4.052

5.  Age-related changes in intracellular cytokine profiles and Th2 dominance in allergic children.

Authors:  Norio Kawamoto; Hideo Kaneko; Masao Takemura; Mitsuru Seishima; Satomi Sakurai; Toshiyuki Fukao; Kimiko Kasahara; Shinichi Iwasa; Naomi Kondo
Journal:  Pediatr Allergy Immunol       Date:  2006-03       Impact factor: 6.377

6.  Immune system alterations in patients with inflammatory bowel disease during remission.

Authors:  Jurgita Sventoraityte; Aida Zvirbliene; Gediminas Kiudelis; Rimantas Zalinkevicius; Aurelija Zvirbliene; Antanas Praskevicius; Limas Kupcinskas; Vytas Tamosiūnas
Journal:  Medicina (Kaunas)       Date:  2008       Impact factor: 2.430

7.  Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease.

Authors:  L Camoglio; A A Te Velde; A J Tigges; P K Das; S J Van Deventer
Journal:  Inflamm Bowel Dis       Date:  1998-11       Impact factor: 5.325

8.  Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.

Authors:  A Diamanti; M S Basso; M Gambarara; B Papadatou; F Bracci; C Noto; M Castro
Journal:  Int J Colorectal Dis       Date:  2008-09-17       Impact factor: 2.571

Review 9.  The immune response in inflammatory bowel disease.

Authors:  Steven J Brown; Lloyd Mayer
Journal:  Am J Gastroenterol       Date:  2007-06-11       Impact factor: 10.864

10.  Reduced intracellular T-helper 1 interferon-gamma in blood of newly diagnosed children with Crohn's disease and age-related changes in Th1/Th2 cytokine profiles.

Authors:  Nina Holland; Jing Dong; Elizabeth Garnett; Nishat Shaikh; Karen Huen; Paul Harmatz; Anthony Olive; Harland S Winter; Benjamin D Gold; Stanley A Cohen; Robert N Baldassano; Barbara S Kirschner; Melvin B Heyman
Journal:  Pediatr Res       Date:  2008-03       Impact factor: 3.756

View more
  3 in total

1.  Sex- and corticotropin-releasing factor receptor 2- dependent actions of urocortin 1 during inflammation.

Authors:  Burcu Hasdemir; Pallavi Mhaske; Sreenivasan Paruthiyil; Elizabeth A Garnett; Melvin B Heyman; Mehrdad Matloubian; Aditi Bhargava
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-06       Impact factor: 3.619

Review 2.  Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease.

Authors:  Tomasz J Ślebioda; Zbigniew Kmieć
Journal:  Mediators Inflamm       Date:  2014-06-17       Impact factor: 4.711

3.  Effect of fresh frozen plasma on the in vitro activation of U937 monocytes: a potential role for the age of blood donors and their underlying cytokine profile.

Authors:  Mariana Patlán; Fausto Sánchez-Muñoz; Luis M Amezcua-Guerra; Adriana Granados; Araceli Páez; Felipe Massó; Ana M Mejía; Angeles Soster; Rafael Bojalil; Lenin Pavón; Luis A Jiménez-Zamudio; Ricardo Márquez-Velasco
Journal:  Biol Res       Date:  2017-12-21       Impact factor: 5.612

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.